532 related articles for article (PubMed ID: 25108425)
1. Vascular and parenchymal amyloid pathology in an Alzheimer disease knock-in mouse model: interplay with cerebral blood flow.
Li H; Guo Q; Inoue T; Polito VA; Tabuchi K; Hammer RE; Pautler RG; Taffet GE; Zheng H
Mol Neurodegener; 2014 Aug; 9():28. PubMed ID: 25108425
[TBL] [Abstract][Full Text] [Related]
2. Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Fryer JD; Simmons K; Parsadanian M; Bales KR; Paul SM; Sullivan PM; Holtzman DM
J Neurosci; 2005 Mar; 25(11):2803-10. PubMed ID: 15772340
[TBL] [Abstract][Full Text] [Related]
3. ApoA-I deficiency increases cortical amyloid deposition, cerebral amyloid angiopathy, cortical and hippocampal astrogliosis, and amyloid-associated astrocyte reactivity in APP/PS1 mice.
Button EB; Boyce GK; Wilkinson A; Stukas S; Hayat A; Fan J; Wadsworth BJ; Robert J; Martens KM; Wellington CL
Alzheimers Res Ther; 2019 May; 11(1):44. PubMed ID: 31084613
[TBL] [Abstract][Full Text] [Related]
4. Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.
Bell RD; Zlokovic BV
Acta Neuropathol; 2009 Jul; 118(1):103-13. PubMed ID: 19319544
[TBL] [Abstract][Full Text] [Related]
5. Murine versus human apolipoprotein E4: differential facilitation of and co-localization in cerebral amyloid angiopathy and amyloid plaques in APP transgenic mouse models.
Liao F; Zhang TJ; Jiang H; Lefton KB; Robinson GO; Vassar R; Sullivan PM; Holtzman DM
Acta Neuropathol Commun; 2015 Nov; 3():70. PubMed ID: 26556230
[TBL] [Abstract][Full Text] [Related]
6. Reduced nitric oxide bioavailability mediates cerebroarterial dysfunction independent of cerebral amyloid angiopathy in a mouse model of Alzheimer's disease.
Merlini M; Shi Y; Keller S; Savarese G; Akhmedov A; Derungs R; Spescha RD; Kulic L; Nitsch RM; Lüscher TF; Camici GG
Am J Physiol Heart Circ Physiol; 2017 Feb; 312(2):H232-H238. PubMed ID: 27836896
[TBL] [Abstract][Full Text] [Related]
7. Endothelial expression of human amyloid precursor protein leads to amyloid β in the blood and induces cerebral amyloid angiopathy in knock-in mice.
Tachida Y; Miura S; Muto Y; Takuwa H; Sahara N; Shindo A; Matsuba Y; Saito T; Taniguchi N; Kawaguchi Y; Tomimoto H; Saido T; Kitazume S
J Biol Chem; 2022 Jun; 298(6):101880. PubMed ID: 35367207
[TBL] [Abstract][Full Text] [Related]
8. Early-onset formation of parenchymal plaque amyloid abrogates cerebral microvascular amyloid accumulation in transgenic mice.
Xu F; Kotarba AE; Ou-Yang MH; Fu Z; Davis J; Smith SO; Van Nostrand WE
J Biol Chem; 2014 Jun; 289(25):17895-908. PubMed ID: 24828504
[TBL] [Abstract][Full Text] [Related]
9. Beta-amyloid pathology in human brain microvessel extracts from the parietal cortex: relation with cerebral amyloid angiopathy and Alzheimer's disease.
Bourassa P; Tremblay C; Schneider JA; Bennett DA; Calon F
Acta Neuropathol; 2019 May; 137(5):801-823. PubMed ID: 30729296
[TBL] [Abstract][Full Text] [Related]
10. Hereditary and sporadic forms of abeta-cerebrovascular amyloidosis and relevant transgenic mouse models.
Kumar-Singh S
Int J Mol Sci; 2009 Apr; 10(4):1872-1895. PubMed ID: 19468344
[TBL] [Abstract][Full Text] [Related]
11. Chronic cerebral hypoperfusion alters amyloid-β peptide pools leading to cerebral amyloid angiopathy, microinfarcts and haemorrhages in Tg-SwDI mice.
Salvadores N; Searcy JL; Holland PR; Horsburgh K
Clin Sci (Lond); 2017 Aug; 131(16):2109-2123. PubMed ID: 28667120
[TBL] [Abstract][Full Text] [Related]
12. LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer's amyloid-β.
Kanekiyo T; Liu CC; Shinohara M; Li J; Bu G
J Neurosci; 2012 Nov; 32(46):16458-65. PubMed ID: 23152628
[TBL] [Abstract][Full Text] [Related]
13. ABCG2 is upregulated in Alzheimer's brain with cerebral amyloid angiopathy and may act as a gatekeeper at the blood-brain barrier for Abeta(1-40) peptides.
Xiong H; Callaghan D; Jones A; Bai J; Rasquinha I; Smith C; Pei K; Walker D; Lue LF; Stanimirovic D; Zhang W
J Neurosci; 2009 Apr; 29(17):5463-75. PubMed ID: 19403814
[TBL] [Abstract][Full Text] [Related]
14. Cerebrovascular dysfunction in amyloid precursor protein transgenic mice: contribution of soluble and insoluble amyloid-beta peptide, partial restoration via gamma-secretase inhibition.
Han BH; Zhou ML; Abousaleh F; Brendza RP; Dietrich HH; Koenigsknecht-Talboo J; Cirrito JR; Milner E; Holtzman DM; Zipfel GJ
J Neurosci; 2008 Dec; 28(50):13542-50. PubMed ID: 19074028
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia exacerbates Alzheimer's disease pathology by way of the β-amyloid fibrinogen interaction.
Chung YC; Kruyer A; Yao Y; Feierman E; Richards A; Strickland S; Norris EH
J Thromb Haemost; 2016 Jul; 14(7):1442-52. PubMed ID: 27090576
[TBL] [Abstract][Full Text] [Related]
16. Differential deposition of amyloid beta peptides in cerebral amyloid angiopathy associated with Alzheimer's disease and vascular dementia.
Haglund M; Kalaria R; Slade JY; Englund E
Acta Neuropathol; 2006 May; 111(5):430-5. PubMed ID: 16555084
[TBL] [Abstract][Full Text] [Related]
17. Loss of clusterin shifts amyloid deposition to the cerebrovasculature via disruption of perivascular drainage pathways.
Wojtas AM; Kang SS; Olley BM; Gatherer M; Shinohara M; Lozano PA; Liu CC; Kurti A; Baker KE; Dickson DW; Yue M; Petrucelli L; Bu G; Carare RO; Fryer JD
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6962-E6971. PubMed ID: 28701379
[TBL] [Abstract][Full Text] [Related]
18. Alzheimer's Disease: The Link Between Amyloid-β and Neurovascular Dysfunction.
Solis E; Hascup KN; Hascup ER
J Alzheimers Dis; 2020; 76(4):1179-1198. PubMed ID: 32597813
[TBL] [Abstract][Full Text] [Related]
19. The blood clotting Factor XIIIa forms unique complexes with amyloid-beta (Aβ) and colocalizes with deposited Aβ in cerebral amyloid angiopathy.
de Jager M; Boot MV; Bol JG; Brevé JJ; Jongenelen CA; Drukarch B; Wilhelmus MM
Neuropathol Appl Neurobiol; 2016 Apr; 42(3):255-72. PubMed ID: 25871449
[TBL] [Abstract][Full Text] [Related]
20. Astrocytic APOE4 removal confers cerebrovascular protection despite increased cerebral amyloid angiopathy.
Xiong M; Wang C; Gratuze M; Saadi F; Bao X; Bosch ME; Lee C; Jiang H; Serrano JR; Gonzales ER; Kipnis M; Holtzman DM
Mol Neurodegener; 2023 Mar; 18(1):17. PubMed ID: 36922879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
